Form 10-Q CVS HEALTH Corp For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Mizuho Recommends Buying CVS (CVS) on Today's Weakness, Driven by Retail
November 8, 2016 8:46 AM ESTMizuho Securities analyst Ann Hynes weighed in on CVS Health (NYSE: CVS) after the company post rare guidance reduction on retail weakness.
Hynes commented, "CVS reported a 3Q beat (adjusted EPS of $1.64 versus consensus $1.57E), but lowered 2016E guidance by 1% at the midpoint. 2017E initial guidance was provided early (usually given in December) and its 10% below our and Street estimates at the mid-point. CVS also provided an updated on its long-term guidance at +10%, which is below current of +10-14% but in-line (or better) than Street expectations given the lack of generic introduction... More



